GLP-1 weight loss

Mochi Health

Checked October 16, 2026 18 sources joinmochi.com ↗

Mochi Health is a membership telehealth service centered on obesity medicine that prescribes brand-name and compounded GLP-1s.

What it is

Members pay a membership fee for provider video visits and care-team support, including insurance and prior-authorization help; medication is billed separately and filled by partner pharmacies or local pickup.

Its site lists brand-name Zepbound, Wegovy, Ozempic, Mounjaro, Foundayo and the Wegovy pill alongside compounded tirzepatide, semaglutide (injectable and pill) and orforglipron, plus metformin.

It also lists hair loss, skincare, longevity, mental health, men's health, menopause, supplements, heart and metabolic care and a pediatrics page.

Prescribes: Brand-name GLP-1s (Zepbound, Wegovy, Ozempic, Mounjaro, Foundayo, Wegovy pill) and compounded semaglutide, tirzepatide and orforglipron (compounded drugs are not FDA-approved)

What it costs

Membership, 12 months paid upfront (about $17/mo)	$1991
Compounded semaglutide injection, 'as low as' (dose-dependent)	$601
Compounded semaglutide pill, 'as low as'	$621
Compounded tirzepatide, 'as low as' (dose-dependent)	$901
Compounded orforglipron, 'as low as'	$311
Wegovy or Ozempic (brand), 'as low as'	$1991
Zepbound (brand), 'as low as'	$2991
Foundayo or Wegovy pill (brand oral), 'as low as'	$1491
Mounjaro (brand), 'as low as'	$4991

Insurance: Visits can be billed to insurance with the copay shown up front; the site offers a coverage check and prior-authorization help. Cash-pay and compounded options exist without insurance.

Prices change often. Check joinmochi.com before you sign up.

By the numbers

Trustpilot: 4.5/5 from about 19,500 reviews; 81% five-star and 9% one-star.2
App Store: 4.9/5 from 17K ratings.4
BBB: 1,422 complaints filed in the last three years; 319 customer reviews.3
The site claims a community of 500,000+ members and 120+ conditions treated.1

Pros and cons

Pros

Homepage lists both brand-name and compounded options with starting prices.1
Membership includes insurance and prior-authorization support, and visits can be billed to insurance.1
BBB lists an A rating and accreditation (since August 2026).3

Cons

Medication is billed separately from the membership fee.1
BBB lists 1,422 complaints in the last three years; complaint pages center on billing after cancellation and refunds.3
Its compounded products are not FDA-approved, and drugmakers Eli Lilly and Novo Nordisk have both sued it over how they were marketed (allegations, not findings).6

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

Reviewers often praise attentive providers, easy scheduling, the app and responsive support.2
Complaints mention missed or late appointments, refill problems, sudden provider changes and worries about shipping temperature.2
Members argued over an August 2026 switch to dose-based medication pricing: Mochi posted that no price went up, while some users said higher tirzepatide doses from one pharmacy rose to about $250.11 13
Some long-time members say they are leaving over price compared with no-membership competitors, while others stay because the treatment is working for them.12
Members describe being moved between several compounding pharmacies over time, with different additives; one user reported receiving another patient's medication, and commenters largely blamed the pharmacy.14 15

Records we found

Official and court records we found in public sources as of October 16, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

Sep 2026
Court
On Lilly's second amended complaint, the court dismissed the Lanham Act claims against Mochi Health and Aequita and let California Unfair Competition Law claims, including a corporate-practice-of-medicine conspiracy theory, proceed. No final judgment was found in this check.10
Apr 2026
Court
On Lilly's amended complaint, Judge Jacqueline Scott Corley allowed the Unfair Competition Law and Lanham Act claims to proceed and dismissed the civil conspiracy claim with leave to amend.8
Nov 2025
Court
The court dismissed Lilly's original complaint for failing to show injury (standing), with leave to amend.7
Aug 2025
Court
Novo Nordisk sued Mochi Health and its medical groups (N.D. Cal., No. 5:25-cv-06563), a trademark and Lanham Act case alleging Mochi implied its compounded semaglutide was FDA-reviewed and showed images of Ozempic pens. Mochi moved to dismiss the second amended complaint in April 2026; no ruling was found in this check.16
Apr 2025
Court
Eli Lilly sued Mochi Health and affiliated medical groups (N.D. Cal., No. 3:25-cv-03534), alongside separate suits against Fella, Willow and Henry Meds, alleging Mochi marketed mass-produced compounded tirzepatide as 'personalized' and misled consumers; Lilly also alleged violations of California's corporate-practice-of-medicine rules.6
Mar 2025
State board
Washington's Pharmacy Quality Assurance Commission issued a Limited Stop Service to Aequita Pharmacy (Kirkland, WA), a compounding pharmacy that filled Mochi orders and was later named with Mochi in Eli Lilly's suit, alleging untrained staff doing sterile compounding and inadequate supervision. The action was against the pharmacy, not Mochi; its resolution was not found in this check.9

Sources

Emerge Care is not affiliated with Mochi Health and earns nothing if you use it. Mochi Health and its logo are trademarks of their owner, used only to identify it. This page lists public facts with sources and is not medical advice or a recommendation. Spotted something wrong or out of date? Email hello@getemergeapp.com and we will fix it.